Rocking Chair Therapy in Elderly With Dementia: Its Effects on Agitation
Rocking
Rocking Chair Therapy: A Non Pharmacological Intervention in Elderly With Dementia, Its Effects in Agitation, Pharmacological Restraint Use, and Pain
1 other identifier
interventional
12
1 country
1
Brief Summary
Patients with dementia exhibit a wide range of behavioral symptoms which include mood disturbances (e.g depression, anxiety), behavior and activity disturbances (e.g agitation, aggression, wandering) and psychotic symptoms (e.g hallucinations and delusions). Behavioral disturbances are a major source of caregiver burden and an important contributor to the decision to admit AD patients to institutionalized long-term care. Among the innovative approaches, rocking chair therapy has been introduced as a potential means for reducing agitation in elderly with dementia. Only few studies evaluated the effect of this therapy on the behavioral symptoms in elderly with cognitive impairment. The results were promising, but not sufficiently significant. We propose to perform this study having as a main goal to evaluate the effect of the rocking chair therapy in agitation for home care residents with dementia. The secondary aim of the study will be the evaluation of psychoactive drugs use as well as pain killers. Cohen Mansfield agitation inventory will be employed for the pre- and post-therapy evaluation. Included subjects will be installed in groups of five, rocking chairs will be placed away from other residents in a semicircle in a corner of the dayroom. The therapy sessions will be held every afternoon, for two hours, under the supervision of the unit psychologist and a master's degree psychology student. During the daily session, each resident should be encouraged to actively rock to reach the goal of 60 minutes of rocking accumulated per day. The total duration of the therapy period will be 6 weeks. The use of pharmacological restraint (neuroleptics, anxiolytics) and pain killers will be evaluated before, during and after the six weeks therapy. The expected outcome is a reduction of agitation among elderly with dementia, as well as a reduction in the use of pharmacological restraint and pain killers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2019
CompletedFirst Posted
Study publicly available on registry
September 24, 2019
CompletedStudy Start
First participant enrolled
October 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2024
CompletedMay 26, 2026
May 1, 2026
3.5 years
August 8, 2019
May 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change of agitation
Change from Baseline agitation at 6 weeks. The agitation will be evaluated using Cohen Mnasfiled agitation inventory a week before therapy, and the week after.
At 6 weeks
Study Arms (1)
Rocking chair therapy
EXPERIMENTALRocking sessions in a safe rocking chair for 2 hours daily for six weeks
Interventions
Rocking sessions in a safe rocking chair for 2 hours daily for six weeks
Eligibility Criteria
You may qualify if:
- resident of the EHPAD / LTC for at least 10 weeks
- subject with cognitive impairment (MMSE \<24) documented according to DSM-5 criteria
- with chronic behavioral disorders such as agitation
- stable from a medical point of view
- without restraint when not in bed
- ability to touch the floor with the toes while sitting in the rocking chair
- ability to sit securely in the rocking chair
- ability to tolerate rocking chair
- Ability to maintain active rocking for at least 5 minutes over a 30-minute period during the three pre-treatment trials
- obligation for all patients to be affiliated to a social security scheme
- signing of the informed consent by the patient and / or his legal representative
You may not qualify if:
- Motor deficiency (example: after-effects of stroke ...) not allowing a secure installation in the chair or preventing an active rocking
- ATCC with vestibular involvement that may lead to vertiginous seizures during rocking
- Aging psychiatric pathology
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nice - Gérontology
Nice, Alpes-Maritime, 06100, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ZAAFRANE Malek, Ph
Centre Hospitalier Universitaire de Nice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2019
First Posted
September 24, 2019
Study Start
October 25, 2019
Primary Completion
April 18, 2023
Study Completion
April 18, 2024
Last Updated
May 26, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share